Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Intangibles (2016 - 2025)

Historic Intangibles for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $19.1 billion.

  • Bristol Myers Squibb's Intangibles fell 1803.75% to $19.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $19.1 billion, marking a year-over-year decrease of 1803.75%. This contributed to the annual value of $19.1 billion for FY2025, which is 1803.75% down from last year.
  • Per Bristol Myers Squibb's latest filing, its Intangibles stood at $19.1 billion for Q4 2025, which was down 1803.75% from $20.5 billion recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Intangibles ranged from a high of $50.8 billion in Q1 2021 and a low of $19.1 billion during Q4 2025
  • Over the past 5 years, Bristol Myers Squibb's median Intangibles value was $32.0 billion (recorded in 2023), while the average stood at $32.7 billion.
  • As far as peak fluctuations go, Bristol Myers Squibb's Intangibles plummeted by 241.0% in 2024, and later plummeted by 3136.14% in 2025.
  • Bristol Myers Squibb's Intangibles (Quarter) stood at $42.5 billion in 2021, then decreased by 15.68% to $35.9 billion in 2022, then decreased by 24.5% to $27.1 billion in 2023, then decreased by 13.91% to $23.3 billion in 2024, then decreased by 18.04% to $19.1 billion in 2025.
  • Its last three reported values are $19.1 billion in Q4 2025, $20.5 billion for Q3 2025, and $21.4 billion during Q2 2025.